Finland Leads the Way Toward the EHDS, but Local Readiness Remains Limited
Finland is moving toward the European Health Data Space (EHDS) with strong national systems, but local readiness, funding, and interoperability remain challenges.
A key challenge in using real-world healthcare data (RWD) is how to standardize data across different healthcare providers and countries.
– Although it is often thought that the data volume in healthcare is enormous, it isn’t. However, the data is diverse, and a large part of it is in free text format, which makes data processing difficult. For example, one distribution center of the leading Finnish delivery and fulfillment companies, Posti, produces as much data in four days as laboratories of the wellbeing services county of Southwest Finland (Varha) does in ten years, says Arho Virkki, Analytics Director of the wellbeing services county of Southwest Finland (Varha). Virkki held a presentation at Medaffcon’s EMMA client event.
Due to the diversity of healthcare data, standardizing methods are needed to facilitate real-world (RWE) research and data-driven decision-making. One method is the OMOP data model (Observational Medical Outcomes Partnership). The OMOP data model is a relational model that collects data in a patient-centric manner.
The Observational Health Data Sciences and Informatics (OHDSI) organization drives the utilization of the OMOP data model. This model standardizes healthcare data and enables uniform processing of data from different sources and regions. In addition to OMOP, other similar data models for leveraging healthcare information exist.
– Many European organizations use OMOP, and its use is increasing. Therefore, I would say that it is the best bet to make right now, says Arho Virkki, Analytics Director of the wellbeing services county of Southwest Finland (Varha).
According to Virkki, whether OMOP will become the dominant model for productivity studies in Finnish hospitals is unclear.
– At least we should be inspired by OMOP. We may consider whether to build our own domestic model for productivity studies. On the other hand, if the welfare counties manage to transfer a lot of their data to the OMOP model, it is entirely possible that the OMOP data model could also be used in productivity studies.
Today, the benefits of OMOP are realized in international research that utilizes data from numerous hospitals across Europe. Combining diverse data would be impossible without a standardized data model.
The wellbeing services county of Southwest Finland (Varha) is involved in the European Medicines Agency’s Data Analysis and Real World Interrogation Network (Darwin). The network conducted a drug utilization study on valproate using the OMOP data model for EMA. In this study, the wellbeing services county of Southwest Finland’s (Varha) biostatistician converted the welfare area’s data into the OMOP model and checked, among other things, the success of data bridging and the functionality of the analysis code.
– We gained a lot of good experience from using the OMOP model. Extracting and translating data into OMOP is not entirely straightforward. However, a common data model is a prerequisite for international research, says Virkki.
Arho Virkki, Analytics Director of the wellbeing services county of Southwest Finland (Varha), spoke about the OMOP data model at Medaffcon’s EMMA customer event in April 2024.
Medaffcon, founded in 2009, is a Nordic research and consulting company specializing in Real-World Evidence, Medical Affairs, and Market Access. With offices in Stockholm, Sweden, and Espoo, Finland, we provide expert services across the Nordic region. Our services combine strong medical and health economic expertise with modern data science.
The company employs some 30 experts. Since 2017, Medaffcon has been a subsidiary of Tamro Oyj and is part of the PHOENIX group, which is a leading provider of healthcare services in Europe.
Finland is moving toward the European Health Data Space (EHDS) with strong national systems, but local readiness, funding, and interoperability remain challenges.
The studies are based on Medaffcon’s Collaboration Research (CORE) dataset – a unique research platform.
Medaffcon develops the Patient Dynamics tool based on customer feedback and user experience.
Data Analysis Lead
MSc (Tech.)
+358 44 314 1597
iiro.toppila@medaffcon.com
Iiro joined Medaffcon in March 2017 as a Biostatistician. For the preceding four years, he has worked as a research assistant in an academic study group, analyzing clinical and genetic patient data. Iiro holds a Master of Science degree in Technology in Bioinformation Technology.
Iiro’s strengths include his strong expertise in statistics and data-analysis, hands-on experience in working with sensitive patient data, and strong interdisciplinary communication skills with experts from various fields. In the field, he is particularly interested in the large data amounts made available with the revolution of technology and how the information received such data can potentially be utilized to draw concrete conclusions, both in order to understand the nature of diseases and to advance the goals of the pharmaceutical industry and patient treatment.
“Machine learning and AI-based solutions will have a major impact on the healthcare sector now and in the future. However, effectively utilizing the already collected and available health-data will have a higher importance in order to improve health-care”.